Avoiding Hypotension in Preterm Neonates
AHIP
1 other identifier
interventional
98
1 country
1
Brief Summary
Objectives Firstly to examine in preterm neonates, whether it is possible to reduce number of hypotensive episodes and use of catecholamines by applying cerebral/peripheral near infrared spectroscopy in combination with predefined interventions and secondly to explore the potential impact on cerebral injury and mortality. Hypothesis By using predefined interventions for changes in cerebral/peripheral oxygenation ratio investigators will reduce hypotensive episodes and use of catecholamines which will reduce cerebral injury and mortality. Methods Cerebral (cTOI) and peripheral-muscle (pTOI) tissue-oxygenation-index (NIRO 300) will be measured for 24h starting \<6 hours postpartum. When cTOI/pTOI ratio increases \>5% within a 6h period, predefined interventions will be performed. Primary outcome parameter will be duration of hypotensive episodes and use of catecholamines during the first 48h after birth. Secondary outcome parameters will be cerebral injury and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2013
CompletedFirst Posted
Study publicly available on registry
July 29, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJanuary 18, 2017
January 1, 2017
3.1 years
July 19, 2013
January 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Time (percentage of hours) of hypotension/use of catecholamines during the first 48 hours
48 hours
Secondary Outcomes (2)
Cerebral injury by cerebral ultrasound
up to 16 weeks
Mortality
up to 16 weeks
Other Outcomes (4)
Neonatal morbidities
up to 16 weeks
Heart rate
48 hours
Blood pressure
48 hours
- +1 more other outcomes
Study Arms (2)
NIRS visible and predefined interventions
EXPERIMENTALNIRS measurements are visible and the patients will be treated according to predefined clinical interventions: If cTOI/pTOI ratio increases \>5% within a six-hours-period echocardiography will be performed and based on results of echocardiography and blood pressure a volume bolus or, if ventilated, modification of ventilation or treatment of patent ductus arteriosus will be considered.
NIRS not visible and treatment as usual
OTHERNIRS measurements are not visible and the patients will be treated according to routine ('treatment as usual')
Interventions
NIRS measurements are visible and the patients will be treated according to predefined clinical interventions: If cTOI/pTOI ratio increases \>5% within a six-hours-period echocardiography will be performed and based on results of echocardiography and blood pressure a volume bolus or, if ventilated, modification of ventilation or treatment of patent ductus arteriosus will be considered.
NIRS not visible and the patients will be treated according to routine
Eligibility Criteria
You may qualify if:
- preterm neonates
- decision to conduct full life support
- written informed consent
- age \<6 hours
- no use of catecholamines before start of NIRS measurements
You may not qualify if:
- no decision to conduct full life support
- no written informed consent
- age \>6 hours
- use of catecholamines before start of NIRS measurements
- congenital malformation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dep. of Pediatrics, Medical University of Graz
Graz, Styria, 8036, Austria
Related Publications (2)
Hoeller N, Baik-Schneditz N, Schwaberger B, Mileder L, Urlesberger B, Pichler G. Cerebral and peripheral muscle oxygenation and perfusion: Course in moderate and late preterm neonates during the first day after birth. Physiol Int. 2020 Jul 17;107(2):267-279. doi: 10.1556/2060.2020.00028.
PMID: 32692715DERIVEDPichler G, Holler N, Baik-Schneditz N, Schwaberger B, Mileder L, Stadler J, Avian A, Pansy J, Urlesberger B. Avoiding Arterial Hypotension in Preterm Neonates (AHIP)-A Single Center Randomised Controlled Study Investigating Simultaneous Near Infrared Spectroscopy Measurements of Cerebral and Peripheral Regional Tissue Oxygenation and Dedicated Interventions. Front Pediatr. 2018 Feb 1;6:15. doi: 10.3389/fped.2018.00015. eCollection 2018.
PMID: 29450194DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gerhard Pichler, MD
Dep. of Pediatrics, Medical University of Graz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. Prof. Dr.
Study Record Dates
First Submitted
July 19, 2013
First Posted
July 29, 2013
Study Start
November 1, 2013
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
January 18, 2017
Record last verified: 2017-01